Isaia Barbieri

Research group leader in the Department of Pathology at the University of Cambridge

ib318@cam.ac.uk

Isaia Barbieri Ph.D. obtained his master degree in biotechnology at the University of Turin in 2008 and his doctoral degree in molecular biotechnology at the University of Turin in 2012.

 

Read more

Isaia completed his Ph. D. training in the Molecular Biotechnology Center at the University of Turin, working on signaling pathways involved in the pathogenesis of Her2 positive breast cancer.
He then moved to the University of Cambridge for his post-doctoral training and worked in the Laboratory of Professor Tony Kouzarides at the Gurdon Institute.
Initially his interests were the epigenetic mechanisms involved in the pathogenesis of blood cancer and specifically he characterizing the inhibition of BET proteins in Myeloproliferative neoplasms.  More recently he switched his interests to the field of epitranscriptomic with a focus on studying the role of m6A (6-methyladenosine) RNA methylation in acute myeloid leukaemia.
Finally, he focused his attention in studying the roles of a different RNA methylation (7-methylguanosine) in lung cancer cellular models.

Research interest

In 2018 Isaia Started his independent research group in the department of pathology, further studying epigenetic and epitranscriptomic mechanisms in cancer cellular models. In particular, the laboratory is interested in studying the interplay between epigenetic and epitranscriptomic modifications of DNA and RNA and identify potential candidates for new cancer treatment.

Donato Bini

Senior researcher, Istituto per le applicazioni del cacolo M.Picone CNR

donato.bini@gmail.com

Dr. Donato Bini graduated in Physics at the University of Rome “Sapienza” in 1989, with the highest grades. At “Sapienza” he also obtained his PhD in Physics in 1995. From 1995 to 1998 he had  a temporary position at the CNR “Istituto per le Applicazione della Matematica” in Naples (IT).

Read more

From 1998 he has a permanent position as a Researcher at the CNR, Istituto per le Applicazioni del Calcolo “M. Picone” Rome (IT), where he is still now in  a Senior Researcher position. He has been the principal investigator  of two research projects of  INDAM (the  Italian National Institute of High Mathematics) on the topic of relativist global position systems and the leader of a CNR joint collaboration project with Venezuela.  Since 2004 he is a contract Professor with the University Campus Bio-Medico in Rome and since 2011 he is a Visiting Professor at the “Institut des Hautes Études Scientifiques” in Paris (FR). He acts as a reviewer for many scientific journals (he has been recognized as Outstanding Reviewer by the IOP journal “Classical and Quantum Gravity” in the years 2017 and 2018).

Research interest

The main topic of  Donato Bini’s  interest is general relativity with special attention to several classical aspects of the theory, like the analysis and the interpretation of  exact solutions of  Einstein’s field equations. In particular, he is interested in  spacetime splitting techniques, the measurement process and the role of the observer in general relativity, particle dynamics in certain fixed gravitational backgrounds, gravitational perturbations, and gravitational waves. Currently, his research activities involve applications of the post-Newtonian approximation of general relativity, gravitational self-force, and the effective-one-body model for the description of the dynamics of  binary systems.

He is an expert user of the Maple™ tensor calculus package and the author of about 200 peer-reviewed papers and 2 books.

Dennis Black

Full Professor of Epidemiology and Biostatistics, Head of Division of Chronic Diseases, UC, University of Florida, San Francisco

dblack@psg.ucsf.edu

Dr. Black has over 20 years of experience investigating osteoporosis and therapies to treat this disease. His most recent research involved the evaluation of treatments for osteoporosis and the risk of fracture.

Read more

The study concluded that benefits of treatments outweigh the risk of rare femoral fractures. The results were published in early 2010 in the New England Journal of Medicine and received extensive media coverage. Dr. Black is currently Principal Investigator, along with Dr. Roberta Ballard, for a multi-center trial (TOLSURF) pioneering treatment for BPD (bronchopulmonary dysplasia) for extremely low birth weight infants.

Research Interests

  • Osteoporosis
  • Clinical trials
  • He has published over 200 peer reviews articles.

Luca Borghi

Head of Department of FAST (Institute of Philosophy of Scientific and Technological Practice), Assistant professor of History of Medicine, Università Campus Bio-Medico di Roma

l.borghi@unicampus.it

Luca Borghi (Bologna, 1962) teaches History of Medicine and History of Science at the University Campus Bio-Medico in Rome, Italy. He is Head of Department of FAST (Institute of Philosophy of Scientific and Technological Practice) of the same University.

Read more

He is a member of the Italian Society for the History of Medicine, coordinator of its Research group about the Italian anatomical theatres (THESA) and co-editor of the Society’s journal Medicina Historica. Since January 2017, he is the Italian National Delegate of the International Society for the History of Medicine; since January 2019 he is the Editor of the International Society’s quarterly Newsletter.

 

Research Interests

His research interests and activities are mainly focused on the “human factor” of medical evolution in the 19th and early 20th centuries and on the material traces left by the history of healthcare. He promoted and coordinates project "Himetop - The History of Medicine Topographic Database "(himetop.net), an international on-line database, which aims to locate, describe and valorise the places of medical and health history, such as ancient hospitals, monuments, birthplaces and tombs of relevant physicians, specialized museums and libraries. His more recent books are a biography of 19th century Italian clinician and statesman, Guido Baccelli, and a history of the Italian paediatric hospital “Giannina Gaslini” in Genoa. He is about to publish a monograph on “William Osler and Italy”. He recently started a biographical research about Sir Aldo Castellani.

Andrea Calcaterra

Assistant Professor of Chemistry and Organic Chemistry, Sapienza Università di Roma, Dipartimento di Chimica e Tecnologie del Farmaco

a.calcaterra@unicampus.it

Andrea Calcaterra received his master degree in chemistry in 2009 at Sapienza University of Rome and obtained his PhD in Pharmaceutical Sciences in 2013, with a thesis on “Chiral supramolecular chemistry of basket resorc[4]arenes”. During this period, he also spent two months at University of Bielefeld, studying gas phase reactions by FT-ICR mass spectrometry.

 

Read more

From 2013, Andrea Calcaterra works as a post-doc in Organic Chemistry at Sapienza University of Rome. From 2017 to 2018, he also spent one year at Università degli studi di Roma “Tor Vergata” as post-doc in Material Science. In 2017, he becomes an adjunct Professor of Organic Chemistry and Chemistry of Natural Organic substances at Sapienza. In 2018, he starts working as an adjunct Professor of Organic Chemistry at Università Campus Bio-medico di Roma; since 2019, he is also an adjunct Professor of Chemistry at Biochemistry propedeutics at Università Campus Bio-medico di Roma.

Research interest

His current research interests focus on the extraction and isolation of organic compounds from natural sources, on the total synthesis of natural products endowed with pharmacological activity and on the study of reactions of derivatization or degradation of natural compounds. He has also expertise in structural elucidation by Nuclear Magnetic Resonance as well as in Mass Spectrometry, for the study in gas phase of reaction and host guest interaction of macrocyclic compounds. He is co-author of 27 publications and 1 patent.

Valerio Chiurchiù

Assistant professor of Biochemistry, Università Campus Bio-Medico di Roma

v.chiurchiu@unicampus.it

Dr. Chiurchiù graduated in Biology in 2007 and obtained a PhD in Immunology in 2011 at University Tor Vergata in Rome. After 2 years of post-doctoral fellowship in Biochemistry at University of Teramo, he joined the Department of Medicine of Campus Bio-Medico University of Rome in 2014 as a post-doctoral fellow in Biochemistry.

Read more

From 2016 Dr. Chiurchiù is Assistant Professor in Biochemistry at University of Rome Campus Bio-Medico. Dr. Chiurchiù’ has been voted Chair Assistant and co-organized the 2015 Gordon Research Seminar on “Endocannabinoid signaling in Neurobiology: from Molecules to Networks” at Lucca, Italy. He is currently engaged in prestigious international collaborations with Prof. Charles Serhan at the Brigham and Women's Hospital, Harvard Medical School of Boston and Prof. Helga de Vries at Amsterdam University. From 2019 he is a visiting assistant professor at Harvard Medical School of Boston. Dr. Chiurchiù is a reviewer and evaluator of several national and international competitive grants, including of the prestigious ERC consolidator grant.  For his latest discoveries, he was awarded the 2018 Galeno Award as Best Young Italian Researcher for experimental and clinical research.

Research interests

He has a vast and consolidated expertise in inflammatory mediators and in the immunomodulatory role of bioactive lipids on immune-biochemistry. His research activity is focused in understanding the pathophysiological role of several families of bioactive lipids (endocannabinoids and specialized pro-resolving lipid mediators) in specific immune cell populations in of both innate and adaptive immunity, with a particular focus on the processes of resolution of inflammation in several paradigms of chronic inflammatory and neurodegenerative diseases, taking advantage of several sophisticated immunological techniques including cell sorting, polychromatic flow cytometry and metabololipidomics. He is Principal Investigator of several grants and author of more than 45 peer-reviewed publications.

Massimo Ciccozzi

Associate Professor of Medical Statistics, Università Campus Bio-Medico di Roma

m.ciccozzi@unicampus.it

Prof. Massimo Ciccozzi obtained a degree in Biological science and a master’s degree in epidemiology and biostatistics, a graduation in molecular Biology (Catholic University of Rome), a graduation in epidemiology and Biostatistics (Johns Hopkins University Baltimore).

Read more

Worked as researcher since 1990 at the National Institute of Health in Rome and is now Associate Professor and director of the Medical Statistic and Molecular Epidemiology Unit at the Campus Bio-Medico University in Rome. He is a consultant epidemiology for WHO in different countries. He made Studies on field epidemiology and surveillance systems and molecular epidemiology.

Research interests

He is expert in phylogenetic and evolutionary analysis of microorganism and infectious diseases. These studies has been also conducted in several countries where Prof Ciccozzi has been named as expert consultant (Albania, Montenegro, Bulgaria, Egypt, Turkey, USA). He has been the Principal Investigator in many National and international project on AIDS. He is epidemiologist expert in Molecular epidemiology, Surveillance System of infectious diseases and global health. He is author of more than 250 international publications, editor and reviewer for many journals.

Roberto Civitelli

Full Professor of Medicine in the Division of Bone and Mineral Disease, Washington University in St. Louis

civitellir@wustl.edu

Prof. Roberto Civitelli is Full Professor of Medicine in the Division of Bone and Mineral Disease, University St. Louis, Washington.

Read more

Research Interests

Cell-cell communication in bone

Overview of research activity: The skeletal tissue is continuously remodeled throughout life, its structure being determined by concurrent genetic, environmental, hormonal, and mechanical factors. Bone remodeling is orchestrated by the coordinated action of different cells types, osteoblasts, osteoclasts, osteocytes and cells of the bone marrow. Most metabolic bone diseases, such as osteoporosis, are the result of an imbalance between bone resorption and formation, with the former prevailing. A defective “coupling” between these two processes may occur via a reduced formation, an increased resorption, or both. The long term goal of the laboratory is to understand the cellular and molecular basis of this tightly regulated process, and to devise mechanisms by which the balance could be modified. Our current research interests are directed toward the biologic function of direct intercellular communication between bone cells via gap junctions and cell-to-cell contact. We have identified molecules of the connexin family of gap junction proteins in human and rodent osteoblastic cell models, including connexin43 and connexin45. These proteins form intercellular channels that allows direct cell-cell communication in osteoblastic networks via transfer of ions and small solutes. We have found that gap junctional communication regulates osteoblastic gene expression, such as osteocalcin and bone sialoprotein, via modulation of signals that flow through the intercellular channels.

Marcello D'Amelio

Full Professor of Human Physiology Università Campus Bio-Medico di Roma

m.damelio@unicampus.it

Marcello D’Amelio, Dr. Neuroscience and M.Sc. in Clinical Experimentation, is Professor of Human Physiology and Coordinator of the integrated course, Fundamentals of Medicine II, in MD Master Degree Program at the School of Medicine, Campus Bio-Medico University of Rome.

Read more

In January 2011, I was appointed as Director of the Laboratory of Molecular Neuroscience at European Centre for Brain Research, Santa Lucia Foundation, Rome, Italy. Since January 2012, I serve, as Director of the Molecular Neuroscience Unit at Medical School University Campus Bio-medico in Rome, where I has been appointed as Full Professor.

I has been awarded the “2013 Bioeconomy Rome, International Prize” for outstanding contributions of young Italian scientist in the field of translational research in neurodegeneration,  and “2015 Raffaele Giuliano Prize” for the quality and originality of the scientific production".

I am supported by Alzheimer's Association's (USA), by the Italian Ministry of Health, and by Farmindustria.

For a full list of scientific publications please check https://orcid.org/0000-0001-6526-1832

Research Interests

I am interested in the cellular and molecular mechanisms that underlie long-lasting changes of synaptic function in both normal, healthy brains and in the brains of those affected by neurological disorders, in particular Alzheimer's Disease (AD) and Parkinson’s Disease (PD). A plethora of techniques is employed, including chemical biology, molecular biology, patch-clamp electrophysiology, calcium imaging, and neurobehavioral paradigms.

Giampaolo Ghilardi

Assistant Professor of FAST (Institute of Philosophy of Scientific and Technological Acting, Università Campus Bio-Medico

g.ghilardi@unicampus.it

 

Read more

Graduated summa cum laude in Philosophy in 2002 at the Università Cattolica of Milan where he obtained the Teaching Qualification in Philosophy and Human Science in 2004, Phd in Bioethics in 2011 at the Università Campus Bio-medico Rome. After 4 years of post-doctoral fellowship in the same University he was appointed Assistant Professor in Moral Philosophy in 2017.
He got the Associate Professor habilitation in 2018.
Member of the Institute of Philosophy of Scientific and Technological Acting, Italian Society of Moral Philosophy, Interdisciplinary Group of Clinical Bioethics and Ethical Consulting in Health Care, Sciences Literature and Arts Academy of Bergamo (moral sciences section), in 2018 he won the Michele Erede Prize with a paper on Precision Medicine.

Research interest

His main interest field is Science Ethics. He devoted several years working on the ethics, anthropology, and epistemology underlying Neurosciences, in particular focusing on free will, ethical dilemmas stemming from neuroscientific approaches, and medical practice. He studied clinical methodology both from the ethical and epistemological perspective, focusing on different steps of clinical reasoning and its logic. He later developed this stream of inquire into the Ethics of scientific and technological acting. His publications (more than 40 and three books) deals with ethical and anthropological issues in Bioethics, Neuroethics, Roboethics, Ethics applied to Medicine, Medicine and Rhetoric, Precision and Personalized Medicine, Medical Humanities. He coauthored two papers on Leonardo da Vinci published by The Lancet (2017, 2019) on the epistemological and ethical issues in Leonardo’s anatomical drawings.

Peter Kreuzaler

Postdoc in Dr Mariia Yuneva’s group at the Francis Crick Institute in London

peter.kreuzaler@crick.ac.uk

Peter Kreuzaler obtained his undergraduate degree in biochemistry from the Free University of Berlin in 2007, and subsequently moved to the University of Cambridge, where he was awarded his PhD in 2011. He then joined Professor Gerard Evan’s group at the University of Cambridge as a postdoctoral research fellow (2012-2017), and currently works at the Francis Crick Institute in London conducting further postdoctoral research in Dr Mariia Yuneva’s group.

 

Read more

He has been lecturing at the University of Cambridge in the fields of molecular biology, cell death, and cancer for a number of years. He ha salso pursued his passion for teaching through the supervision of PhD students and Master students. Throughout his career, he has received numerous Fellowships, most notably a Junior Research Fellowship at Trinity College Cambridge.

Research interest

His research has spanned various fields of molecular and cancer biology. During his PhD Dr Kreuzaler identified a novel pathway of cell death as the driving force behind the physiological process of post-lactational mammary gland involution. He then moved into the study of breast cancer, where he found that different clones of cancer can complement each other’s signalling, thus building a synergy between them. His current works focus on cancer metabolism and developing methods to image metabolic heterogeneity and superimpose it to the genetic heterogeneity found in tumours.

David Leslie

Full Professor of Diabetes and Autoimmunity Queen Mary University, London

r.d.g.leslie@qmul.ac.uk

Professor David Leslie is consultant physician at St Bartholomew's Hospital and Professor of Diabetes and Autoimmunity at the Blizard Institute, Queen Mary, University of London. He was recently elected President of The Association of Physicians of Great Britian and Ireland.

Read more

He qualified and trained at Imperial College and subsequently at King's College Hospital and Royal Victoria Infirmary, Newcastle. He was an MRC Travelling Fellow at the University of Chicago, USA, and Welcome Trust Senior Clincal Research Fellow at both King's College and Charing Cross and Westminster Medical Schools. He has an interest in the cause of autoimmune diabetes through the study of twins and disease syndromes.

Research Interests

Professor Leslie has been Principle Investigator of three major EU programmes (EXALT, BLUEPRINT and Action LADA) and Founding Chairman of T1DUK. His research is based on the use of cutting-edge technology applied to unique cohorts (e.g. twins and adult onset autoimmune diabetes patients) to define the nature and origins of type 1 diabetes. These results led to work as Principle Investigator of three major EU programmes (EXALT, BLUEPRINT and Action LADA). He has been awarded lectures on several continents, e.g. Royal College of Physicians (London) Lecture, The Lily Lecture (Ireland), Niall O’Mara Lecture (Ireland), Silver Jubilee Oration (India), Xiangya Lecture (China). He held Visiting Chairs in USA (Chicago and Kansas) and Europe (Rome) and is an Emeritus Professor in China (Central South University). He was Senior Examiner Chinese University Hong Kong in 2013 and am currently am the founding Chairman of T1DUK, a UK consortium of leading UK researchers set up to investigate and prevent type 1 diabetes. Notable awards include: a Medical Research Council Travelling Fellowship to USA, the Royal College of London Leonard Simpson Fellowship and Wellcome Trust Senior Fellowship in Clinical Science. He was co-author of an award-winning textbook (BMA Book of the Year Award 2009), Director of the Mendel Institute, Rome, Italy, Co-Editor of Diabetes Metab. Res. Rev., Reviews Editor of Diabetic Medicine and served on the Editorial Board of Diabetes Care.

Alessandro Loppini

Assistant Professor in Applied Physics at Università Campus Bio-Medico di Roma

a.loppini@unicampus.it

Alessandro Loppini, PhD in Biomedical Engineering (2016) at University Campus Bio-Medico of Rome. Postdoctoral Fellow at University Campus Bio-Medico of Rome (2017-2018). Assistant Professor of Applied Physics since November 2018 at University Campus Bio-Medico of Rome.

 

Read more

Alessandro Loppini graduated in Biomedical Engineering at “Università Campus Bio-Medico di Roma” in 2011 with the highest grades. In 2016, he obtained his PhD in Biomedical Engineering at “Università Campus Bio-Medico di Roma”. His PhD research focused on mathematical modelling of excitable biological tissues, with particular regards to beta-cells electrophysiology. As a PhD student, he spent visiting periods in the Department of Information Engineering at “Università degli studi di Padova” and in the Center of Polymer Studies at the “Boston University”. From 2016 to 2018, he was granted with a postdoctoral fellowship at the Department of Engineering of “Università Campus Bio-Medico di Roma”. Since 2018, he is Assistant Professor of Applied Physics at University Campus Bio-Medico of Rome.

Research interest

His research activity focuses on the mathematical modelling of biological processes and cells physiopathology, with particular regards to excitable cells and media, such as pancreatic β-cells, neurons and heart tissue. In this context, main research objectives are related to the identification of key molecular mechanisms at the basis of insulin release, information flow within neuronal networks and of arrhythmias and fibrillation development in heart. He is also interested in complex network theory and its application to biological systems, numerical computing applied to the resolution of ODE and PDE systems, parallel computing, and statistical analyses applied to biological and medical data.

Mauro Maccarrone

Full Professor of Biochemistry, Università Campus Bio-Medico di Roma

m.maccarrone@unicampus.it

Mauro Maccarrone, Dr. Enzymology and Bio-Organic Chemistry, is Professor and Chair of Biochemistry and Molecular Biology, and Coordinator of the Bachelor’s Degree in Food Science and Human Nutrition at the School of Medicine, Campus Bio-Medico University of Rome. 

Read more

He is the Director of the Laboratory of Lipid Neurochemistry at the European Center for Brain Research (CERC)/IRCCS Santa Lucia Foundation, Rome, Italy. He has been awarded the “4th Royan International Research Award for Reproductive Biomedicine”, the “2007 IACM Award for Basic Research” and the “2016 Mechoulam Award”, and has been Chair of the 2015 Gordon Research Conference on “Cannabinoid Function in the CNS”. He serves as referee for several journals of science (including Science, Nature Medicine, JAMA, PNAS, Blood) and for several scientific associations (including German Research Foundation (DFG), The Wellcome Trust, the Medical Research Council (MRC), the Gordon Research Conferences (GRC)), and the NASA Postdoctoral Program (NPP). In the field of lipid signaling, he published > 485 full papers, of which 55 with I.F. ≥ 9 and 45 with ≥ 100 citations (total I.F. > 2410; citations >15180, h-index = 64 according to Scopus).
         

Research Interests

His research activity is focused in understanding the pathophysiological role of several families of bioactive lipids (endocannabinoids and specialized pro-resolving lipid mediators).

Ahuva Nissim

Full Professor of Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London

a.nissim@qmul.ac.uk

Ahuva Nissim graduated in Molecular Immunology in 1992 from the Weizmann Institute of Science in Israel and was trained as a postdoctoral fellow at the MRC Centre for Protein Engineering in Cambridge until 1995. During this period she developed phage display semi-synthetic human antibody library, the so call ‘Nissim’ library which has been used worldwide.

Read more

In November 2000 she was appointed as a Senior Lecturer at Queen Mary University. Her studies are interdisciplinary and involve translational research at the William Harvey Research Institute and with intensive worldwide collaborations. Her studies have been mostly focused on the mechanisms that lead to the formation of disease tissue-specific pathogenic proteins and the exploitation of identified pathogenic proteins to develop platform technologies for novel disease - and tissue-specific, diagnosis and targeted treatment.

Research Interests

The main research interest focuses on development of diseased tissue specific diagnosis and targeted immunotherapy to novel neoantigens produced specifically in diseased tissue. The role of oxidants in generation of neoantigen in the diseased tissues as a results of oxidative post-translational modification is investigated. Research is focused on arthropathies and type 1 diabetes but other autoimmune condition such as periodontal diseases have been studied. Hence, a specific targeted immunotherapy for the treatment of arthropathies has been developed. Ongoing research activities include the development of novel human antibody repertoires for engineering of new treatment modalities.

Ann Schwartz

Full Professor University of California, San Francisco Department of Epidemiology & Biostatistics

aschwartz@psg.ucsf.edu

Ann V. Schwartz, PhD, MPH is Full Professor, Department of Epidemiology and Biostatistics at the University of California, San Francisco. Dr. Schwartz's research focuses on the epidemiology and etiology of fractures, osteoporosis, and falls in older adults with diabetes.

Read more

Research Interests

She is currently the PI of ACCORD BONE, an ancillary study to the ACCORD trial in older adults with type 2 diabetes, examining the effects of intensive glycemic control and TZD use on skeletal health. She is pursuing investigations into the reasons for reduced bone strength in type 2 diabetes, including the role of marrow fat, advanced glycation endproducts, and cortical porosity. Dr. Schwartz serves as the Director of the San Francisco Coordinating Center DXA Quality Assurance Group of Medicine.

Vittoradolfo Tambone

Full Professor of Legal Medicine, Università Campus Bio-Medico di Roma

v.tambone@unicampus.it

Vittoradolfo Tambone graduated in Medicine at “La Sapienza” University of Rome, obtained a PhD in Bioethics  at “Sacred Hearth” University of Rome, and another Phd  in Moral Theology in “Holy Cross” University of Rome.

Read more

At present he is: a) Full Professor of Legal Medicine and Bioethics, b) Coordinator of Bioethics Service of the University Hospital Campus Bio-Medico of Rome, c) Member of the Executive Committee of The Institute of Scientific and Technological Action of the University Campus Bio-Medico of Rome, d) Visiting professor at The University of Navarra (Pamplona-Spain) and at Catholic University of Buenos Aires (Buenos Aires – Argentina), e) Coordinator of the working group of the Italian Legal Medicine College on Legal Medicine, Bioethics and Robotics, f) Member of the Study Group of the Italian Society of Legal Medicine and Insurance (SIMLA) on Ethical Consultancy (GIBCE), f) Member of several Editorial Boards of international scientific journals, g) Faculty Member of the UCBM Doctoral program in Biomedical Science and Bioethics.

Research interests

He has a vast and consolidated expertise in: a) Clinical Bioethics applied in special way in end life management, best practice ethics and ethical consulting; b) Applied Ethics to Robotics and AI; c) Medical Humanities.  His research activity is focused in improving professionalism in the field of take care through a personalistic and multidimensional vision of research and assistance. From the methodological point of view he proposes “Conscious and Cooperative Reduction” and from the ethical one the “Well done work Ethic”.

He is Author of 6 books edited in 6 languages and of more than 60 peer-reviewed publications.

Giorgio Vivacqua

MD and PhD in Human Anatomy, Neurology specialist, Research Associate at the Department of Clinical Neuroscience, The University of Cambridge

giorgio83.vivacqua@gmail.com

Giorgio Vivacqua is Research Associate at the Department of Clinical Neuroscience of The University of Cambridge. PhD in Human Anatomy at the Sapienza University of Rome and Capital Medical University of Beijing, China. Specialist in Neurology. I have been Professor of Human Anatomy at the International Medical School - Sapienza University of Rome. My research and clinical activity is mainly focused on neurodegeneration and Movement Disorders.

 

Read more

Master Degree, Medicine and Surgery - Sapienza University of Rome; PhD, Anatomy - Sapienza University of Rome and Capital Medical University, Beijing, China; from 2011 to 2013: post-Doctoral researcher at the Department of Human Anatomy, Sapienza University of Rome; Specialist in Neurology. Professor of Human Anatomy, International Medical School, Sapienza University of Rome, until 2017. From October 2017 to September 2018: Research Fellowship Award European Academy of Neurology and International Movement Disorders Society - Department of Clinical Neuroscience, The University of Cambridge; from October 2018 to date: Research Associate, Department of Clinical Neurosciences, The University of Cambridge.

Research interest

His research activity focuses on two main fields: determination of the physiological and pathogenic role of α- synuclein in Parkinson's disease and atypical parkinsonisms, with particular attention to the detection of α-synuclein in pheripheral tissues and biological fluids, in order to develop a possible biomarker for synucleinopathies. Study of the spinal cord in experimental models of parkinsonsisms, in order to understand the anatomical bases underlying clinical symptoms poorly responsive to dopaminergic therapy and probably related to the involvement of the spinal cord.

Selected Publications

-Vivacqua et al., 2019. Motor neurons pathology after chronic exposure to MPTP in mice. Neurotox Res. DOI 10.1007/s12640-019-00121-y

-Vivacqua et al., 2019. Salivary alpha-synuclein in the diagnosis of Parkinson’s disease and progressive sopranuclear palsy. Parkinsonism Relat Disord. pii: S1353-8020(19)30060-4.

-Vivacqua et al., 2016. Abnormal salivary total and oligomeric alpha-synuclein in Parkinson’s disease.

PLoS One;11(3):e0151156.

-Vivacqua et al., 2012. Loss of Spinal motor neurons and alteration of alpha-synuclein immunostaing in MPTP induced parkinsonism in mice. J Chem Neuroanat;44(2):76-85.

-Vivacqua et al., 2011. Spinal cord and parkinsonism: neuromorphological evidences in humans and experimental studies. J Chem Neuroanat;42(4):327-40.

-Vivacqua et al., 2009. Immunolocalization of alpha-synuclein in the rat spinal cord by two novel monoclonal antibodies. Neuroscience;158(4):1478-87.

Christine Watson

Full Professor of Cell and Cancer Biology, Division of Cellular and Molecular Pathology, Department of Pathology University of Cambridge

cjw53@cam.ac.uk

I graduated with an Honours degree in Biochemistry from the University of Glasgow and a PhD in Molecular Genetics from Imperial College London. Following postdoctoral work at the Institute of Cancer Research in London and the University of St Andrews, I moved to the Roslin Institute in Edinburgh where I set up my own laboratory working on mammary gland biology.

Read more

I moved to Cambridge in 1998. I am a member of the Nuffield Council on Bioethics and Deputy Editor of Breast Cancer Research. I am a Fellow of the Higher Education Academy. In 2017 I was elected to the Fellowship of the Academy of Medical Sciences.

Research Interests

Mammary gland development and breast cancer.

Research in my laboratory is focused on understanding the molecular and genetic mechanisms that control two essential processes for mammary gland development: commitment of stem cells to the luminal and basal lineages and the execution of cell death and tissue remodelling during post-lactational regression (involution). We use insights gained from this work to develop new approaches for the detection and treatment of breast cancer.